￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Is osimertinib (Tagrisso) suitable for the treatment of lung squamous cell carcinoma and analysis of its efficacy

2026-02-01 22:25:32

Check Details
Can I eat immediately after taking Eltrombopag (Revlan) and what are my dietary recommendations?

2026-02-01 22:25:32

Check Details
Possible side effects and treatment methods during taking Roprostim (Huierning)

2026-02-01 22:25:32

Check Details
What to do if Midostaurin can cause an allergic skin reaction

2026-02-01 22:25:32

Check Details
Does long-term use of cabergoline cause excessive gastric acid secretion?

2026-02-01 22:25:32

Check Details
Which groups are not suitable for taking Momelotinib and tips on potential risks

2026-02-01 22:25:32

Check Details
Introduction to the domestic launch time and market supply situation of Bikken Pronol Tablets (Bituvi)

2026-02-01 22:25:32

Check Details
Deuterated colexitinib (decavatinib) approved indications and latest guidelines

2026-02-01 22:25:32

Check Details
What specific symptoms can Apremilast (Otelor) improve in patients with psoriasis?

2026-02-01 22:25:32

Check Details
Once you start taking Valganciclovir, do you need to take it for a long time?

2026-02-01 22:25:32

Check Details
Research on the potential application of osimertinib (Tagrisso) in the treatment of breast cancer

2026-02-01 22:25:32

Check Details
Differences and usage comparison between avatrombopag and eltrombopag (Revlan)

2026-02-01 22:25:32

Check Details
Category
相关知识